Remote audits and inspections are here to stay. But how can pharmaceutical firms prepare for this new reality?
On May 18, three industry experts participated in the Redica Systems virtual panel discussion webinar, “Remote Audits.” Redica Systems Senior GMP Quality Expert Jerry Chapman, Senior GMP Expert Barbara W. Unger, and Pharmatech Associates, Inc. Executive Director of Regulatory Compliance Stephanie Gaulding answered questions about remote audits and inspections based on their expertise and experience.
Their responses were covered in a series of five articles, which are listed below.
- Redica Systems Experts Address Remote Audit/Inspection Landscape
- Embracing New Technologies for Remote Audits and GMP Inspections
- Remote Audits and Document Sharing
- Onsite versus Remote Audits
- Remote Audit Best Practices Q&A
If you missed the webinar, you can still access the recording here.
Subscribe to Redica Insights
Get quality and compliance insights from our experts in your inbox
Or request a demo to talk with one of our team members.